# M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule

> **NCT03297983** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** M7583

## Key facts

- **NCT ID:** NCT03297983
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-09
- **Primary completion:** 2017-12-06
- **Final completion:** 2017-12-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03297983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03297983, "M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03297983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*